Nexthera Capital’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | $7.49M | Buy |
142,305
+55,206
| +63% | +$2.9M | 6.23% | 6 |
|
2019
Q1 | $4.61M | Sell |
87,099
-134,563
| -61% | -$7.12M | 5.59% | 7 |
|
2018
Q4 | $9.1M | Sell |
221,662
-327,569
| -60% | -$13.4M | 3.75% | 7 |
|
2018
Q3 | $20.9M | Buy |
549,231
+145,139
| +36% | +$5.52M | 4% | 7 |
|
2018
Q2 | $18.3M | Buy |
404,092
+88,945
| +28% | +$4.02M | 2.83% | 7 |
|
2018
Q1 | $15.2M | Buy |
315,147
+3,631
| +1% | +$175K | 2.51% | 11 |
|
2017
Q4 | $12.3M | Buy |
311,516
+41,441
| +15% | +$1.63M | 2.26% | 9 |
|
2017
Q3 | $8.39M | Sell |
270,075
-70,025
| -21% | -$2.17M | 2.16% | 14 |
|
2017
Q2 | $9.3M | Buy |
340,100
+135,600
| +66% | +$3.71M | 4.05% | 8 |
|
2017
Q1 | $7.54M | Buy |
204,500
+144,500
| +241% | +$5.32M | 3.85% | 8 |
|
2016
Q4 | $867K | Buy |
+60,000
| New | +$867K | 0.51% | 29 |
|